Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trialJürgen Rech, Georg Schett, Bernhard Manger et al.|The Lancet|2024Cited by 134
Patient experiences, attitudes, and profiles regarding artificial intelligence in rheumatology: a German national cross-sectional survey studyHannah Labinsky, Johannes Knitza, Philipp Klemm et al.|Rheumatology International|2025Cited by 8